Ways to Increase Girth: The 2026 A-to-F Evidence Grade

Introduction: Why “Increase Girth” Searches Deserve a Real Evidence Standard

A man who types “increase girth” into a search bar meets an immediate wall of contradiction. Forums promise results from daily exercises. Supplement ads claim “natural” breakthroughs. Device marketers show before-and-after photos with no source data. None of it comes with a consistent way to judge credibility.

This article applies a formal A-to-F evidence-grading rubric to every major girth method men research. The model draws on clinical evidence hierarchies used in medicine, such as the USPSTF and GRADE systems. Six methods are reviewed:

  • Jelqing
  • Vacuum pumps
  • Traction extenders
  • Oral supplements
  • Autologous fat grafting
  • Injectable fillers

Each grade is tied to specific data points, including the 2026 meta-analysis in the International Journal of Impotence Research (IJIR), the American Urological Association’s (AUA) position statement, FDA recall data, and peer-reviewed case reports on PLA and PMMA fillers. Grades do not come from opinion or marketing copy.

The intended reader is an educated, high-earning professional aged 25 to 54 who wants facts before considering a consultation. This piece is purely informational: it promises no outcomes, applies no pressure, and gives readers a clear framework for separating evidence from myth.

How the A-to-F Grading Rubric Works

Each method is assessed against four criteria:

  1. Quality and size of clinical evidence. A meta-analysis outweighs a small trial, a small trial outweighs anecdote, and anecdote outweighs nothing.
  2. Regulatory or professional body position. This includes the AUA, the FDA, and the European Association of Urology (EAU).
  3. Safety and complication profile, including reversibility.
  4. Durability of measured girth outcomes, reported in centimeters.

The gap between an A and a C is not simply whether a method works. An A requires controlled, peer-reviewed, reproducible data, along with a risk profile that is both acceptable and correctable.

Methods with no clinical evidence at all, including branded supplement blends and unregulated “enlargement” gadgets, receive no letter grade. They are flagged as ungraded due to insufficient data, which is what separates this rubric from a ranked listicle.

The rubric also treats length claims and girth claims separately. Many studies blur the two, even though the underlying physiological mechanisms are very different.

Before the Grades: Why Most Men Researching Girth Have Normal Anatomy

Responsible evidence grading starts with psychology, not centimeters.

A 2020 systematic review of 17 studies covering more than 1,100 men seeking enlargement found that the great majority measured within the normal anatomical range. Other research found that only about 2% of men are genuinely satisfied with their size, while roughly 85% of partners report satisfaction. For most men, the concern is one of confidence and self-image rather than a physical deficit.

Formal guidance reflects this: the EAU’s 2023 guidance states that men of normal size who seek augmentation should be referred for psychological assessment first. Clinicians may use tools such as the Cosmetic Procedure Screening Scale (COPS-P) to identify penile dysmorphic disorder (PDD).

Screening does not exist to turn men away. It exists to make sure treatment helps. One study of properly screened men after filler treatment found statistically significant improvements in:

  • Genital self-image (P<0.001)
  • Self-esteem (P=0.008)
  • Reduction in PDD symptoms (P=0.002)

Screening is therefore built into how this rubric defines a “high-value” treatment.

Grade F: Oral Supplements and “Natural” Pills

Grade: F. Supplements have no credible mechanism and no clinical trials supporting girth increase. They also carry a documented, active safety hazard.

As of October 2026, the FDA’s Health Fraud Product Database held 441 sexual-enhancement and energy-product notifications. Recent cases show the pattern:

  • Erectus Plus (2026): FDA analysis found undeclared sildenafil, tadalafil, and testosterone propionate.
  • Ultimate Forza Male Supplement (October 2026): Recalled after testing identified undeclared sildenafil, tadalafil, and dapoxetine.

These products are not just ineffective. Many are unregulated drug cocktails that can interact dangerously with nitrates, blood pressure medication, or existing cardiac conditions. No pill, capsule, or “natural enhancement” product has ever shown girth increase in controlled research. This grade is a safety warning as much as an evidence score.

Grade F: Jelqing and Manual Stretching Exercises

Grade: F. No clinical studies specifically support girth gains from jelqing.

The only controlled small-scale trial followed 7 men performing 200 strokes per day for three months. It measured an average length increase of just 0.13 inches and produced no credible girth data.

The documented risks are real:

  • Scar tissue and hematoma formation
  • Temporary erectile dysfunction
  • Abnormal curvature caused by repeated mechanical trauma

Jelqing is a clear example of a method with high search volume and failing evidence. It is popular on forums, has essentially no peer-reviewed support, and carries meaningful injury risk.

Grade D: Vacuum Erection Devices (Penis Pumps)

Grade: D. Pumps produce visible engorgement, but it is temporary and does not change tissue durably.

Most measurable “gains” are swelling that fades within hours. The 5th International Consultation on Sexual Medicine, an international consensus review, concluded that clinical trials have not found vacuum therapy effective for penis enlargement.

Pumps do have legitimate, evidence-supported clinical uses. They help preserve girth and length after prostatectomy and support management of Peyronie’s disease. That rehabilitative value is why pumps earn a D rather than an F. However, that use is not the cosmetic girth increase most searchers want.

Grade D: Traction Devices and Penile Extenders

Grade: D for girth. Traction devices have real evidence behind them, but the evidence supports length, not girth.

A landmark Italian trial published in BJU International found a 32% increase in flaccid length over six months. It reported no significant increase in penile girth, which averaged 10.4 cm both before and after treatment.

A comprehensive 2024 review reached the same conclusion. It found that extenders offer a favorable safety profile for length gain but “should not be recommended in men exclusively concerned with increasing penile girth.”

For a man whose specific goal is girth, extenders are backed by evidence for a different outcome entirely. This is one of the most common misconceptions in the category.

Grade C: Autologous Fat Grafting

Grade: C. Meta-analysis data show a measurable effect, but official professional guidance actively discourages the method.

The 2026 IJIR meta-analysis reported a pooled mean girth increase of 1.99 cm from autologous surgical fat grafts. The AUA and Urology Care Foundation take a different view. They state that they “consider subcutaneous fat injection for increasing penile girth to be a procedure which has not been shown to be safe or efficacious.”

The aggregate number hides several clinical problems:

  • Fat resorbs unevenly.
  • Results can be lumpy or asymmetric.
  • Harvesting fat requires surgery, which adds its own risks.

The meta-analysis authors caution that their exploratory overall girth estimate “has limited meaning for counselling an individual patient.” They also conclude that the evidence does not support routine cosmetic use outside research settings.

Grade C: Permanent and Semi-Permanent Fillers (PLA, PMMA/Metacrill, Silicone)

Grade: C. These fillers can produce real, documented girth change, but their irreversibility and complication rates are serious liabilities.

A 2025 peer-reviewed case report series described granuloma formation as one of the most severe complications after polylactic acid (PLA) injection. The PMMA filler Metacrill became popular in Mexico and reported 86% satisfaction. It also showed high complication rates, nodules that were difficult to remove, and poor re-injectability caused by fibrosis.

The core issue for patients is correction. PLA, PMMA, and silicone cannot be dissolved or adjusted if the result is uneven, becomes infected, or is simply disliked. An elective cosmetic decision becomes permanent. This is why reversibility is the deciding factor in the next section.

Grade A: Reversible Hyaluronic Acid (HA) Filler Under Medical Supervision

Grade: A. Reversible HA filler is the only method in this review that combines measurable efficacy, a strong safety and reversibility profile, and sustained outcome data through 48 weeks.

Efficacy data:

The reversibility advantage: In the 155-patient series, 12.3% of men needed cosmetic correction with hyaluronidase or botulinum toxin. That figure is better understood as proof of correctability than as a failure rate. The same correction is impossible with PLA, PMMA, or fat.

Screening is part of the grade. The EAU’s recommendation for pre-treatment psychological assessment is treated here as a required part of an A-grade protocol, not an optional extra. Even the supportive meta-analysis stresses caution for purely cosmetic use in anatomically normal men, which makes careful screening essential.

The A grade applies only to reversible HA administered by a qualified medical provider, in a clinical setting, with staged dosing. It does not extend to every injectable marketed for enhancement.

Methods We Withheld a Grade From

Some products are deliberately left ungraded. These include unbranded enlargement gadgets, proprietary herbal blends with no registered trials, and unregulated topical creams.

The distinction matters. An F means clinical evidence exists and that evidence is negative. “Ungraded” means there is no peer-reviewed data to evaluate at all, which is itself a red flag. A rigorous rubric has to acknowledge the limits of the available evidence rather than force a grade onto marketing claims that cannot be verified.

The Full Grade Summary at a Glance

  • Oral supplements: F. Evidence anchor: FDA recalls and hidden drugs. Reversible: not applicable; the risk is a safety hazard.
  • Jelqing: F. Evidence anchor: no girth studies. Reversible: injury risk.
  • Vacuum pumps: D. Evidence anchor: effects are temporary only. Reversible: yes, because gains fade.
  • Traction extenders: D. Evidence anchor: improve length, not girth. Reversible: not applicable.
  • Autologous fat: C. Evidence anchor: not endorsed by the AUA. Reversible: no.
  • Permanent fillers (PLA, PMMA, silicone): C. Evidence anchor: granuloma and fibrosis risk. Reversible: no.
  • HA filler (medically supervised): A. Evidence anchor: 2026 meta-analysis plus 48-week data. Reversible: yes, with hyaluronidase.

Only one method combines quantifiable efficacy data, acceptance by mainstream clinical practice, and a built-in corrective mechanism. Individual results still vary.

What a Medically Supervised HA Filler Consultation Involves

A responsible consultation begins with an in-depth anatomical evaluation and a frank discussion of goals. Psychological screening consistent with EAU guidance comes before any treatment plan is proposed.

Treatment is usually staged. Volume is added across several visits instead of in one dramatic session. This approach supports symmetry and reduces risk, and it matches outcome data showing that men who receive multiple treatments achieve larger, more predictable cumulative results.

Cost: Pricing starts at $7,500 and increases depending on the patient’s desired results. Treatment is priced by the syringe. Most men start with a minimum of 10 syringes, and the average first procedure involves about 15 syringes. Final cost depends on individual anatomy and goals.

Recovery and timeline: Visible change typically appears quickly. In current published data, most outcomes stabilize and remain consistent through 48 weeks.

A reputable provider will raise hyaluronidase correction as a built-in safety net from the start, not as an afterthought.

Questions to Ask Before Choosing a Provider

Readers can use the following questions to evaluate any clinic:

  • Material: Is the filler a reversible HA-based product, or a permanent or semi-permanent material such as PLA, PMMA, or silicone?
  • Experience: How many procedures has the provider performed? Is treatment staged, or delivered in a single session?
  • Screening: Does intake include psychological screening or a thorough, goals-based consultation consistent with EAU practice?
  • Correction: What options exist if the patient is dissatisfied after treatment?

The point of these questions is patient empowerment. A provider who answers them clearly and without hesitation is showing the transparency the evidence demands.

Conclusion: Reading the Evidence Before Reading the Marketing

The grades tell a consistent story. The most heavily marketed DIY methods, jelqing and supplements, fail on evidence and carry real safety risks. Mechanical tools such as pumps and extenders have legitimate but narrow uses that do not address girth. Older injectable approaches, autologous fat and permanent fillers, produce measurable change but come with documented complication and irreversibility concerns, according to the AUA and 2025 case report data.

Reversible HA filler under medical supervision is the only method in this review to earn an A. That grade rests on 2026 meta-analytic data, confirmatory real-world studies, and a built-in correction mechanism.

This article is informational guidance for evaluating methods, not a guarantee of personal outcomes. Individual results vary and require an in-person medical evaluation. The instinct to research carefully before acting is the right one, because evidence literacy is the first step toward a confident decision.

Next Step: Get a Personalized, Evidence-Based Consultation

Men who have worked through the evidence may be ready to replace forum threads and marketing claims with an informed conversation with a qualified provider.

Stoller Medical Group (Penis Enlargement New York City) is built around the safety-first, staged, medically supervised filler approach described in the A-grade section. The practice has performed more than 15,000 procedures under the leadership of board-certified physician Dr. Roy B. Stoller. It has five locations:

Free consultations offer a low-commitment way to receive individualized guidance. That includes a candid discussion of whether a man is an appropriate candidate for treatment at all. The goal is not a promise of specific results. It is a clear, evidence-based answer to the question each reader came here to resolve.